Cargando…
Is human papillomavirus vaccination likely to be a useful strategy in India?
Two vaccines that protect against infection by some of the oncogenic human papillomavirus (HPV) subtypes have recently been licensed for use in population-based vaccination strategies in many countries. However, these products are being promoted as ‘cervical cancer vaccines’ based on inadequate data...
Autores principales: | Gupta, Sudeep, Kerkar, Rajendra A., Dikshit, Rajesh, Badwe, Rajendra A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889025/ https://www.ncbi.nlm.nih.gov/pubmed/24455622 http://dx.doi.org/10.4103/2278-330X.119887 |
Ejemplares similares
-
Efficacy and safety of human papillomavirus vaccine for primary prevention of cervical cancer: A review of evidence from phase III trials and national programs
por: Basu, Partha, et al.
Publicado: (2013) -
Does HPV vaccination prevent cervical cancer?
por: Miller, Anthony B.
Publicado: (2013) -
The National Cancer Grid of India
por: Pramesh, C. S., et al.
Publicado: (2014) -
Institutional external peer review: A unique National Cancer Grid initiative
por: Raghunadharao, D., et al.
Publicado: (2015) -
Authors’ Reply
por: Gupta, Sudeep, et al.
Publicado: (2014)